意外发现血红蛋白病C/β°地中海贫血。
Unexpected discovery of hemoglobinopathy C/β° thalassemia.
作者信息
Bouyarmane Wafaa, Uwingabiye Jean, Biaz Asmaa, Rachid Achraf, Mechal Youness, Dami Abdellah, Bouhsain Sanae, Ouzzif Zhor, El Machtani Idrissi Samira
机构信息
Department of Clinical Biochemistry and Toxicology Mohammed V Military Teaching Hospital Faculty of Medicine and Pharmacy Mohammed V University Rabat Morocco.
出版信息
Clin Case Rep. 2018 Sep 21;6(11):2117-2120. doi: 10.1002/ccr3.1815. eCollection 2018 Nov.
Abstract
High performance liquid chromatography (HPLC) is the current method of choice for the detection of hemoglobinopathies and the quantification of A2 and fetal hemoglobin. We are describing a case where a double heterozygosity C/beta-thalassemia was fortuitously identified, during assaying HBA1c, by HPLC.
摘要
高效液相色谱法（HPLC）是目前用于检测血红蛋白病以及定量检测血红蛋白A2和胎儿血红蛋白的首选方法。我们描述了这样一个病例，在通过HPLC检测糖化血红蛋白A1c（HBA1c）的过程中，意外发现了一例C/β地中海贫血双重杂合子。
相似文献
1
Unexpected discovery of hemoglobinopathy C/β° thalassemia.
Clin Case Rep. 2018 Sep 21;6(11):2117-2120. doi: 10.1002/ccr3.1815. eCollection 2018 Nov.
2
Case Report: Abnormally Low Glycosylated Hemoglobin A1c Caused by Clinically Silent Rare β-Thalassemia in a Tujia Chinese Woman.
Front Endocrinol (Lausanne). 2022 May 4;13:878680. doi: 10.3389/fendo.2022.878680. eCollection 2022.
3
Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Clin Biochem. 2015 Jul;48(10-11):698-702. doi: 10.1016/j.clinbiochem.2015.04.001. Epub 2015 Apr 11.
4
[Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].
Invest Clin. 2004 Dec;45(4):309-15.
5
εγ-Thalassemia, a New Hemoglobinopathy Category.
Clin Chem. 2023 Jul 5;69(7):711-717. doi: 10.1093/clinchem/hvad038.
6
Evaluation of role of HPLC (Merits & Pitfalls), in the diagnosis of various hemoglobinopathies & thalassemic syndromes.
Indian J Pathol Microbiol. 2021 Jul-Sep;64(3):518-523. doi: 10.4103/IJPM.IJPM_709_20.
7
A reliable and high throughput HPLC-HRMS method for the rapid screening of β-thalassemia and hemoglobinopathy in dried blood spots.
Clin Chem Lab Med. 2023 Jan 16;61(6):1075-1083. doi: 10.1515/cclm-2022-0706. Print 2023 May 25.
8
Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases.
Asian J Transfus Sci. 2016 Jan-Jun;10(1):105-10. doi: 10.4103/0973-6247.175424.
9
A novel double heterozygous Hb Fontainebleau/HbD Punjab hemoglobinopathy.
Clin Biochem. 2015 Sep;48(13-14):904-7. doi: 10.1016/j.clinbiochem.2015.05.020. Epub 2015 May 31.
10
Erroneous HbA1c results in a patient with elevated HbC and HbF.
Clin Chim Acta. 2016 Nov 1;462:153-157. doi: 10.1016/j.cca.2016.09.017. Epub 2016 Sep 21.
本文引用的文献
1
[Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects].
Ann Biol Clin (Paris). 2014 Nov-Dec;72(6):639-68. doi: 10.1684/abc.2014.1015.
2
Hemoglobinopathies in North Africa: a review.
Hemoglobin. 2010;34(1):1-23. doi: 10.3109/03630260903571286.
3
Beta-thalassemia.
Genet Med. 2010 Feb;12(2):61-76. doi: 10.1097/GIM.0b013e3181cd68ed.
4
Quantification of HbA(2) in patients with and without beta-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems.
Am J Clin Pathol. 2009 Mar;131(3):357-62. doi: 10.1309/AJCP28QKSOPHYOBC.
5
Molecular basis of beta-thalassemia in Morocco: possible origins of the molecular heterogeneity.
Genet Test. 2008 Dec;12(4):563-8. doi: 10.1089/gte.2008.0058.
6
[Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Tunis Med. 2006 Nov;84(11):687-96.
7
HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.
Hum Mutat. 2007 Feb;28(2):206. doi: 10.1002/humu.9479.
8
[Good practices for the study of hemoglobin].
Ann Biol Clin (Paris). 2003 Jul-Aug;61(4):401-9.
9
Inherited haemoglobin disorders: an increasing global health problem.
Bull World Health Organ. 2001;79(8):704-12. Epub 2001 Oct 24.
10
Anthropological approach to the heterogeneity of beta-thalassemia mutations in northern Africa.
Hum Biol. 1994 Jun;66(3):369-82.
Zotero 插件